8th Global Pharmacovigilanc and Drug Safety Summit
|8th Global Pharmacovigilanc and Drug Safety Summit
|July 06-07, 2017
|Kuala Lumpur, Malaysia
Conference Series LLC extends its welcome to the 8th Global Pharmacovigilance& Drug Safety Summit in July 06-07, 2017 at Kuala Lumpur, Malaysia with the theme “Innovations in Pharmacovigilance for Systematic safety and Management”. Conference Series LLC, through its Open Access Initiative, is committed to making genuine and reliable contributions to the scientific community.
Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development.